S1PR4 deficiency leads to a decrease in breast cancer metastasis to lung and suppression of tumor growth accompanied by reduction in suppressive immune cells and increased number of tumoricidal lymphocytes, namely cytotoxic CD8+ T-cells [17]. Here, S1PR4 is linked to neoplasm.